Picton Mahoney Asset Management’s Avidity Biosciences RNAM Stock Holding History

Picton Mahoney Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-425,000	Closed	-$30.7M	–	1391
2025 Q4	$30.7M	Buy	+425,000	New	+$27.5M	0.24%	75
2025 Q2	–	Sell	-56	Closed	-$1K	–	1144
2025 Q1	$1K	Buy	+56	New	+$1.74K	﹤0.01%	870

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Picton Mahoney Asset Management's RNAM Position: Q1 2026 in Review

Picton Mahoney Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 425,000 shares — an estimated $30.7M sold.

Picton Mahoney Asset Management first reported a position in RNAM in Q1 2025 and held it in 2 quarters. The position peaked at $30.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Picton Mahoney Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Picton Mahoney Asset Management sold 425,000 Avidity Biosciences shares in Q1 2026, an estimated $30.7M.
Picton Mahoney Asset Management first reported a position in Avidity Biosciences in Q1 2025 and held it in 2 quarters.
Picton Mahoney Asset Management's Avidity Biosciences position peaked at $30.7M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.